Skip to content

H.R. 5526 · 119th Congress (2025–2027)

Biosimilar Red Tape Elimination Act

To improve the requirements for making a determination of interchangeability of a biological product and its reference product.

CRS summary not yet available.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 5526’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. August Pfluger (R-TX-11)
Cosponsors
10 cosponsors

1 original · 9 later

6 R · 4 D

  1. Rep. Greg Landsman (D-OH-1)· Original · Sep 19, 2025
  2. Rep. Jake Auchincloss (D-MA-4)· Later · Oct 17, 2025
  3. Rep. Dan Crenshaw (R-TX-2)· Later · Nov 10, 2025
  4. Rep. Gabe Vasquez (D-NM-2)· Later · Dec 9, 2025
  5. Rep. Burgess Owens (R-UT-4)· Later · Feb 4, 2026
  6. Rep. Randy Fine (R-FL-6)· Later · Mar 9, 2026
  7. Rep. Blake D. Moore (R-UT-1)· Later · May 21, 2026
  8. Rep. Eric Sorensen (D-IL-17)· Later · Jun 4, 2026
  9. Rep. Craig A. Goldman (R-TX-12)· Later · Jul 15, 2026
  10. Rep. Robert J. Wittman (R-VA-1)· Later · Jul 21, 2026
Policy area
Health
Subjects
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Licensing and registrations
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Sep 19, 2025
    1. Jul 20, 2026 · Markup

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Biosimilar Red Tape Elimination Act

    Display title, Short title · Introduced in House

  2. To improve the requirements for making a determination of interchangeability of a biological product and its reference product.

    Official title · Introduced in House